Metraipolis › archive › dc_b3edecb7a0f2
Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical… — Europe PMC PMID:41635510
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41635510
- DOI
- 10.34133/research.1105
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T04:30:04.530Z
- SHA-256 of the archived text
a7604a4fa521b8279a8d6093361895aae26481ca84a1628ede10c304f742c737- Stable URL of this page
https://metraipolis.com/documento/dc_b3edecb7a0f2
How to cite
Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical… — Europe PMC PMID:41635510 — Europe PMC (en), https://europepmc.org/article/MED/41635510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b3edecb7a0f2 (Metraipolis archive dc_b3edecb7a0f2, sha256 a7604a4fa521b8279a8d6093361895aae26481ca84a1628ede10c304f742c737)
BibTeX
@misc{dcb3edecb7a0f2,
title = {Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical… — Europe PMC PMID:41635510},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41635510},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b3edecb7a0f2; sha256 a7604a4fa521b8279a8d6093361895aae26481ca84a1628ede10c304f742c737},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41635510. Agents can read the archived copy with the MCP tool read_document.